A 24-year-old woman with CML underwent allogeneic BMT in August 1995 from a
one-antigen HLA mismatched brother. Conditioning included BuCy2 and CsA an
d MTX were used to prevent GVHD. In July 1997 she developed right leg pain,
lytic bone lesions of distal femur and a solid mass of soft tissue. Histol
ogical diagnosis of malignant fibrous histiocytoma was made. Despite treatm
ent with surgery and chemotherapy (doxorubicin and ifosfamide), the patient
died 1 year later with local recurrence of the tumor and liver, lung and b
rain metastases. The CML was in CR.